← All stocks

LeonaBio, Inc.

LONA Net buying

CIK 0001620463 #4535 in the set updated 17 Sep 2026

Bought (120 mo)

$62.12M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$247.44K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$247.44K

35 of 35 sales

Net

+$61.87M

+$61.87M against sales at will

By person

16 insiders · 79 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

PERCEPTIVE ADVISORS LLC entity

Director

$30.56M (7)

—

+$30.56M

3,755,672

$20.17M

—

EDELMAN JOSEPH

Director

$18.00M (1)

—

+$18.00M

3,114,805

$16.73M

+657.5%

RTW INVESTMENTS, LP entity

10% owner

$12.75M (1)

—

+$12.75M

2,668,913

$14.33M

+595.4%

Romano Kelly A

Director

$303.63K (4)

—

+$303.63K

80,715

$433.44K

+25,524%

Gengos Andrew

CFO and Chief Business Officer

$243.02K (10)

$4.24K (2)

+$238.78K

97,532

$523.75K

—

MILESON GLENNA

Chief Financial Officer

$142.25K (1)

$7.03K (1)

+$135.22K

159,930

$858.82K

+95.1%

Litton Mark James

PRESIDENT and CEO

—

$105.25K (7)

−$105.25K

77,615

$416.79K

—

PICKERING GRANT

Director

$60.35K (2)

—

+$60.35K

25,783

$138.45K

+3,193%

MOEBIUS HANS

Chief Medical Officer

$45.24K (2)

—

+$45.24K

91,482

$491.26K

—

CHURCH KEVIN

CHIEF SCIENTIFIC OFFICER

—

$36.09K (7)

−$36.09K

25,178

$135.21K

—

Worthington Mark

GENERAL COUNSEL and CCO

—

$35.92K (7)

−$35.92K

18,376

$98.68K

—

San Martin Javier

CHIEF MEDICAL OFFICER

—

$29.81K (4)

−$29.81K

15,887

$85.31K

—

Lenington Rachel

COO and CDO

—

$19.73K (3)

−$19.73K

20,870

$112.07K

—

JOHNSON JAMES A

Director

$12.00K (1)

—

+$12.00K

5,000

$26.85K

—

Renninger Robert

CHIEF FINANCIAL OFFICER

—

$9.38K (4)

−$9.38K

15,851

$85.12K

—

FLUKE JOHN M JR

Director

—

155,346

$834.21K

+171.7%

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 3,943,887 to 39,439,326 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 175

Amendments (4/A) skipped 8

Filings about a different issuer 0

Unreadable filings 0

Joint filings 10

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 35

Transactions with no price 0

Shares from compensation/vesting 7,251,452

Sales filed before the plan box existed 5

History held since 22 Sep 2020